Gary Reinl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gary Reinl has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Amanda Lh Chen
Engineering & Management of Advanced Technology, Chang Jung University, Taiwan, Republic of China
1 shared publication- Anish Bajaj
Bajaj Chiropractic Clinic, New York, NY 10010, USA
1 shared publication - B. William Downs
Department of Neurosurgery, Weill Cornel School of Medicine, New York, NY, USA
1 shared publication - Eric R. Braverman
Department of Clinical Neurology, Path Foundation NY, New York, NY, USA
1 shared publication - John Giordano
The Kenneth Blum Behavioral & Neurogenetic Institute, Austin, TX 78701, USA
1 shared publication - Kenneth Blum
Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 40700, Israel
1 shared publication
Latest Publications
- Open Access
- 10 February 2010
- Published by Springer Nature in Cases Journal
- Vol. 3 (1) , 54
Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series
Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave® device therapy and program.
- 10 February 2010
- Published by Springer Nature in Cases Journal
- Vol. 3 (1) , 54
Open AccessHealing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series
Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave® device therapy and program.